Clinical Trials Browser

NIH × Fibrosarcoma × Imatinib Mesylate × Clear all

NCT00031915 2013-06-19

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Phase 2 Completed

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00084630 2013-02-28

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Phase 2 Completed

Fibrosarcoma, Sarcoma, Dermatofibrosarcoma